IL-10 suppresses calcium-mediated costimulation of receptor activator NF-κB signaling during human osteoclast differentiation by inhibiting TREM-2 expression

Journal of Immunology

Volumn 183, Issue 4, 2009, Pages 2444-2455

  Park Min, Kyung Hyun ^a   Ji, Jong Dae ^a,b   Antoniv, Taras ^a   Reid, Alicia C ^c   Silver, Randi B ^c   Humphrey, Mary Beth ^d   Nakamura, Mary ^e   Ivashkiv, Lionel B ^a,f  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Korea University College of Medicine   (South Korea)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; INTERLEUKIN 10; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ITAM; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFATC1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; GROWTH INHIBITOR; IL10 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; TREML2 PROTEIN, HUMAN;

ARTICLE; CALCIUM SIGNALING; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; OSTEOCLAST; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-10; MICE; OSTEOCLASTS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTOR CROSS-TALK; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 70149090443     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804165     Document Type: Article

References (58)

1. Asagiri, M., and H. Takayanagi. 2007. The molecular understanding of osteoclast differentiation. Bone 40: 251-264.
2. Arai, F., T. Miyamoto, O. Ohneda, T. Inada, T. Sudo, K. Brasel, T. Miyata, D. M. Anderson, and T. Suda. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors. J. Exp. Med. 190: 1741-1754.
3. Tanaka, S., K. Nakamura, N. Takahasi, and T. Suda. 2005. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol. Rev. 208: 30-49. (Pubitemid 41746383)
4. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889-901.
5. Takayanagi, H. 2007. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304. (Pubitemid 46480961)
6. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, et al. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428: 758-763.
7. Mocsai, A., M. B. Humphrey, J. A. Van Ziffle, Y. Hu, A. Burghardt, S. C. Spusta, S. Majumdar, L. L. Lanier, C. A. Lowell, and M. C. Nakamura. 2004. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. USA 101: 6158-6163.
8. 3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176: 877-888.
9. Paloneva, J., T. Manninen, G. Christman, K. Hovanes, J. Mandelin, R. Adolfsson, M. Bianchin, T. Bird, R. Miranda, A. Salmaggi, et al. 2002. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 71: 656-662.
10. Paloneva, J., M. Kestila, J. Wu, A. Salminen, T. Bohling, V. Ruotsalainen, P. Hakola, A. B. Bakker, J. H. Phillips, P. Pekkarinen, et al. 2000. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 25: 357-361.
11. Cella, M., C. Buonsanti, C. Strader, T. Kondo, A. Salmaggi, and M. Colonna. 2003. Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J. Exp. Med. 198: 645-651. (Pubitemid 37040398)
12. Klesney-Tait, J., I. R. Turnbull, and M. Colonna. 2006. The TREM receptor family and signal integration. Nat. Immunol. 7: 1266-1273.
13. Takayanagi, H. 2005. Mechanistic insight into osteoclast differentiation in osteoimmunology. J. Mol. Med. 83: 170-179.
14. Takegahara, N., H. Takamatsu, T. Toyofuku, T. Tsujimura, T. Okuno, K. Yukawa, M. Mizui, M. Yamamoto, D. V. Prasad, K. Suzuki, et al. 2006. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat. Cell Biol. 8: 615-622.
15. Humphrey, M. B., L. L. Lanier, and M. C. Nakamura. 2005. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol. Rev. 208: 50-65.
16. Hamerman, J. A., J. R. Jarjoura, M. B. Humphrey, M. C. Nakamura, W. E. Seaman, and L. L. Lanier. 2006. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177: 2051-2055.
17. Mao, D., H. Epple, B. Uthgenannt, D. V. Novack, and R. Faccio. 2006. PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J. Clin. Invest. 116: 2869-2879.
18. Sato, K., A. Suematsu, T. Nakashima, S. Takemoto-Kimura, K. Aoki, Y. Morishita, H. Asahara, K. Ohya, A. Yamaguchi, T. Takai, et al. 2006. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 12: 1410-1416.
19. Teitelbaum, S. L. 2006. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res. Ther. 8: 201.
20. Takayanagi, H., S. Kim, K. Matsuo, H. Suzuki, T. Suzuki, K. Sato, T. Yokochi, H. Oda, K. Nakamura, N. Ida, et al. 2002. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416: 744-749.
21. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408: 600-605.
22. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
23. Owens, J. M., A. C. Gallagher, and T. J. Chambers. 1996. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J. Immunol. 157: 936-940.
24. Sasaki, H., L. Hou, A. Belani, C. Y. Wang, T. Uchiyama, R. Muller, and P. Stashenko. 2000. IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J. Immunol. 165: 3626-3630. (Pubitemid 32057266)
25. +-Th1-cell-associated alveolar bone loss in vivo. Infect. Immun. 74: 4927-4931.
26. Sasaki, H., Y. Okamatsu, T. Kawai, R. Kent, M. Taubman, and P. Stashenko. 2004. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J. Periodontal Res. 39: 432-441.
27. Al-Rasheed, A., H. Scheerens, A. K. Srivastava, D. M. Rennick, and D. N. Tatakis. 2004. Accelerated alveolar bone loss in mice lacking interleukin-10: late onset. J. Periodontal Res. 39: 194-198.
28. El Kasmi, K. C., A. M. Smith, L. Williams, G. Neale, A. D. Panopoulos, S. S. Watowich, H. Hacker, B. M. Foxwell, and P. J. Murray. 2007. Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated antiinflammatory signaling pathway. J. Immunol. 179: 7215-7219.
29. Weaver, B. K., E. Bohn, B. A. Judd, M. P. Gil, and R. D. Schreiber. 2007. ABIN-3: a molecular basis for species divergence in interleukin-10-induced antiinflammatory actions. Mol. Cell. Biol. 27: 4603-4616.
30. Evans, K. E., and S.W. Fox. 2007. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol. 8: 4.
31. Mohamed, S. G., E. Sugiyama, K. Shinoda, H. Taki, H. Hounoki, H. O. Abdel-Aziz, M. Maruyama, M. Kobayashi, H. Ogawa, and T. Miyahara. 2007. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Bone 41: 592-602.
32. Antoniv, T. T., and L. B. Ivashkiv. 2006. Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages. Arthritis Rheum. 54: 2711-2721.
33. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17: 6419.
34. Park-Min, K. H., N. V. Serbina, W. Yang, X. Ma, G. Krystal, B. G. Neel, S. L. Nutt, X. Hu, and L. B. Ivashkiv. 2007. FcγRIII-dependent inhibition of interferon-γ responses mediates suppressive effects of intravenous immune globulin. Immunity 26: 67-78.
35. Schotte, R., M. Nagasawa, K. Weijer, H. Spits, and B. Blom. 2004. The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J. Exp. Med. 200: 1503-1509.
36. Ho, H. H., and L. B. Ivashkiv. 2006. Role of STAT3 in type I interferon responses: negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem. 281: 14111-14118.
37. 2+ and pH in living cells. Methods Cell Biol. 81: 415-433.
38. Silver, R. B., K. S. Poonwasi, N. Seyedi, S. J. Wilson, T. W. Lovenberg, and R. Levi. 2002. Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings. Proc. Natl. Acad. Sci. USA 99: 501-506.
39. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
40. + monocytes isolated from peripheral blood. J. Bone. Miner. Metab. 25: 36-45.
41. Ikeda, F., R. Nishimura, T. Matsubara, S. Tanaka, J. Inoue, S. V. Reddy, K. Hata, K. Yamashita, T. Hiraga, T. Watanabe, et al. 2004. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114: 475-484.
42. Miyazaki, T., H. Katagiri, Y. Kanegae, H. Takayanagi, Y. Sawada, A. Yamamoto, M. P. Pando, T. Asano, I. M. Verma, H. Oda, et al. 2000. Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts. J. Cell. Biol. 148: 333-342.
43. 2+ flux and ERK activation via phosphorylation of phospholipase Cγ1. J. Biol. Chem. 280: 8397-8406.
44. 2+]i oscillation regulation. Genes Dev. 21: 1803-1816.
45. Turnbull, I. R., S. Gilfillan, M. Cella, T. Aoshi, M. Miller, L. Piccio, M. Hernandez, and M. Colonna. 2006. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol. 177: 3520-3524.
46. Epple, H., V. Cremasco, K. Zhang, D. Mao, G. D. Longmore, and R. Faccio. 2008. Phospholipase Cγ2 modulates integrin signaling in the osteoclast by affecting the localization and activation of Src kinase. Mol. Cell. Biol. 28: 3610-3622. (Pubitemid 351732899)
47. 2+/CaM-dependent kinases: from activation to function. Annu. Rev. Pharmacol. Toxicol. 41: 471-505.
48. Seales, E. C., K. J. Micoli, and J. M. McDonald. 2006. Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival. J. Cell. Biochem. 97: 45-55.
49. Humphrey, M. B., M. R. Daws, S. C. Spusta, E. C. Niemi, J. A. Torchia, L. L. Lanier, W. E. Seaman, and M. C. Nakamura. 2006. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J. Bone Miner. Res. 21: 237-245.
50. Murray, P. J. 2005. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl. Acad. Sci. USA 102: 8686-8691.
51. Zhou, L., A. A. Nazarian, and S. T. Smale. 2004. Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway. Mol. Cell. Biol. 24: 2385-2396.
52. Kwon, O. H., C. K. Lee, Y. I. Lee, S. G. Paik, and H. J. Lee. 2005. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. Biochem. Biophys. Res. Commun. 335: 437-446.
53. Zhang, L., X. Feng, and J. M. McDonald. 2003. The role of calmodulin in the regulation of osteoclastogenesis. Endocrinology 144: 4536-4543.
54. Pestka, S., C. D. Krause, D. Sarkar, M. R. Walter, Y. Shi, and P. B. Fisher. 2004. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22: 929-979.
55. Murray, P. J. 2007. The JAK-STAT signaling pathway: input and output integration. J. Immunol. 178: 2623-2629.
56. Inui, M., Y. Kikuchi, N. Aoki, S. Endo, T. Maeda, A. Sugahara-Tobinai, S. Fujimura, A. Nakamura, A. Kumanogoh, M. Colonna, and T. Takai. 2009. Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12. Proc. Natl. Acad. Sci. USA 106: 4816-4821.
57. Kim, N., M. Takami, J. Rho, R. Josien, and Y. Choi. 2002. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195: 201-209.
58. Ochi, S., M. Shinohara, K. Sato, H. J. Gober, T. Koga, T. Kodama, T. Takai, N. Miyasaka, and H. Takayanagi. 2007. Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc. Natl. Acad. Sci. USA 104: 11394-11399.